Dialysis Rounds A Dialysis Case Presentation and Discussion Edited by Roger A. Rodby : Long‐Term Intravenous Sodium Thiosulfate in the Treatment of a Patient with Calciphylaxis
- 28 September 2005
- journal article
- case report
- Published by Wiley in Seminars in Dialysis
- Vol. 18 (5) , 431-434
Abstract
Calciphylaxis is a disabling and life‐threatening complication that primarily affects patients who are dialysis dependent. This disease entity is characterized by calcification, intimal hypertrophy, and thrombosis of small vessels, which results in necrotizing, nonhealing ulcers. The development of these lesions portends a grim prognosis, as they are often accompanied by severe and sometimes fatal infectious complications. Although several strategies aimed at treating and preventing this affliction have been reported in the literature, the outcome for most patients with calciphylaxis remains quite poor. We describe an anuric hemodialysis patient who developed severe calciphylaxis that proved refractory to conventional treatment. Following extensive debridement of several wounds, intravenous sodium thiosulfate was utilized as an adjunctive therapy four times a week. Within 6 months, excellent wound healing ensued as well as a dramatic improvement in the lesions that were not previously resected. Aside from occasional nausea, these treatments were well tolerated, despite the development of an anion gap metabolic acidosis. After 34 months of continued treatment the patient remains free from disease recurrence and has demonstrated no untoward effect of prolonged therapy. In an effort to delineate the pharmacokinetics of this drug in a hemodialysis patient, serum thiosulfate levels were obtained 15 minutes after infusion as well as before and after subsequent dialysis treatments. Consistent with prior studies in anuric canines, we found measurable quantities of the drug more than 50 hours after treatment, in addition to a markedly elevated half life of 478 minutes. However, given the lack of significant toxicity, as well as a dramatic clinical improvement, we feel that sodium thiosulfate may have an important adjunctive role in the treatment of calciphylaxis in dialysis patients.Keywords
This publication has 16 references indexed in Scilit:
- Risks of chronic metabolic acidosis in patients with chronic kidney diseaseKidney International, 2005
- Rapid resolution of calciphylaxis with intravenous sodium thiosulfate and continuous venovenous haemofiltration using low calcium replacement fluid: case reportNephrology Dialysis Transplantation, 2005
- Metabolic acidosis in maintenance dialysis patients: Clinical considerationsKidney International, 2003
- The evolving clinical features of calciphylaxisKidney International, 2003
- Hyperbaric oxygen in the treatment of calciphylaxis: a case seriesNephrology Dialysis Transplantation, 2001
- The Uremic Gangrene Syndrome: Improved Healing in Spontaneously Forming Wounds Following Subtotal ParathyroidectomyPlastic and Reconstructive Surgery, 1996
- Sodium Thiosulfate in the Treatment of Tumoral Calcifications in a Hemodialysis Patient without HyperparathyroidismNephron, 1996
- Sodium Thiosulphate in the Treatment of Renal Tubular Acidosis I with NephrocalcinosisScandinavian Journal of Urology and Nephrology, 1994
- Sodium Thiosulfate Treatment of Tumoral Calcinosis in Patients with End-Stage Renal DiseaseRenal Failure, 1990
- Systemic Calciphylaxis RevisitedAmerican Journal of Nephrology, 1981